In patients with T2D and CKD who have not achieved individualized glycemic targets despite use of metformin and SGLT2i, or who are unable to use those medications, the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines6 recommend long-acting GLP-1RA
Even if youve been denied coverage for a weight loss drug in the past, its possible that you still havent exhausted all your options to access the brand name GLP-1 medications
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder
This bowl is easy to adjust in thickness and portion size, which makes it a flexible option when hunger varies
Monitor how your appetite feels, how your energy levels respond, whether fatigue patterns change, and how your relationship with food shifts